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Introduction
The Asia-Pacific region has a high prevalence of
viral hepatitis and hepatocellular carcinoma [1,2].
Economic progress has led to increased ethanol
consumption and changes in drinking behavior
[3,4], which have resulted in an increased number
of cases of alcoholic liver disease in Taiwan. Ethanol
abuse is not uncommon among those with chronic
viral hepatitis. Alcoholism may increase viral repli-
cation and exacerbate liver injury, which results in
the progression of chronic viral hepatitis to liver
failure, cirrhosis and hepatocellular carcinoma
[5–7]. In alcoholic liver disease, diminished food
intake and morphologic and functional alterations
in intestinal mucosa cause malnutrition [8,9].
Malnutrition aggravates alcoholic liver disease and
increases mortality [10]. Depression has a more im-
mediate mortality risk among men with alcohol-
ism [11]. Alcoholism is a worldwide public health
problem.
Pathogenesis
In viral hepatitis B and C, liver injuries are mainly
caused by cellular immune responses against infect-
ed hepatocytes [12]. In viral hepatitis, the histologic
features include lymphocytes around hepatocellu-
lar necrosis, portal inflammation, piecemeal necro-
sis, and portal fibrosis [13]. Different from viral
hepatitis, the liver injuries in alcoholic liver disease
consist of oxidative stress-related hepatocellular ne-
crosis and stellate cell-related fibrogenesis [14,15].
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Damage caused by free radicals and lipid peroxi-
dation lead to ballooning changes in hepatocytes
and the formation of Mallory bodies. Mallory bodies
are folded and unfolded proteins in response to oxi-
dative stress; Mallory bodies consist of abnormal ker-
atins, ubiquitin, heat shock proteins, and the protein
p62 [16]. Tumor necrosis factor-α induces the for-
mation of proinflammatory cytokines, which cause
chemotaxis and aggregation of polymorphonuclear
leukocytes around the ballooning hepatocytes [17].
Ethanol-induced hypoxia, lipid peroxidation and
acetaldehyde activate the stellate cells to increase
matrix production and fibrogenesis [18–20].
Clinical Features
The clinical classification of alcoholic liver disease is
based on the pathologic findings of fatty liver, alco-
holic hepatitis and alcoholic cirrhosis [21]. Fatty liver
is also found in patients with alcoholic hepatitis
and alcoholic cirrhosis. A clinical attack of acute alco-
holic hepatitis can occur in patients with alcoholic
cirrhosis.
Fatty liver
Fatty liver is the most common morphologic change
in alcoholic liver disease. Nicotinamide adenine di-
nucleotide (NADH), a metabolite of ethanol gener-
ated under alcohol dehydrogenase, causes increased
formation of fatty acids and decreased oxidation of
fatty acids [22]. Acetaldehyde, another metabolite
of the alcohol dehydrogenase and cytochrome P450
2E1 (CYP2E1) pathways, may cause mitochondrial
dysfunction [23].
Alcoholic fatty liver is often asymptomatic.
Alcoholic liver disease is evident only after identifi-
cation of hepatomegaly. Alcoholic fatty liver is re-
versible following abstinence from ethanol abuse.
Mildly abnormal aminotransferases and bilirubin
levels are often found in patients with alcoholic
steatosis [24]. The elevated indirect bilirubin levels
reflect hemolysis. Zieve syndrome is characterized
by an acute metabolic condition following with-
drawal from prolonged alcohol abuse, and includes
hemolytic anemia, hyperlipoproteinemia, jaundice,
and abdominal pain [25]. Aspartate aminotrans-
ferase (AST) levels are usually higher than alanine
aminotransferase (ALT) levels, with a high AST/ALT
ratio of greater than 2 [26]. The AST and ALT levels
are often less than 300 IU/L. The glutamyl transpep-
tidase levels are often elevated. Patients with alco-
holic steatosis may develop hypertriglyceridemia
and macrocytosis with increased mean cell volume.
Desialylated ferritin (carbohydrate-deficient trans-
ferrin) is formed by the reduced attachment of 
carbohydrate moieties to transferrin in patients
with prolonged heavy alcohol consumption [27].
Carbohydrate-deficient transferrin is a sensitive and
specific marker for alcohol abuse.
Liver biopsy is the most sensitive and specific
method for evaluating the degree of hepatic injury
and fibrosis to help therapeutic decision making
[28,29]. The fatty change is mainly macrovesicular
at zone 2 and 3 [30]. Macrovesicular fatty change
is the accumulation of triglycerides within the cyto-
plasm of hepatocytes which displace the nuclei.
Mitochondrial dysfunction leads to the enlarge-
ment of mitochondria, known as megamitochon-
dria, and ballooning of hepatocytes [31]. Perivenular
and sinusoidal fibrosis are the thin intraluminal fi-
brosis in terminal hepatic venules and surrounding
sinusoids [32,33]. Perivenular and sinusoidal fibrosis
can be found in patients with alcoholic fatty liver,
and a small number of Mallory bodies are often
found in the perivenular zone.
The sonographic features of alcoholic fatty liver
are hepatomegaly, increased echogenicity, vascular
blurring, loss of diaphragm definition, and deep at-
tenuation [34,35]. Thickened abdominal wall and
liver fibrosis may generate sonographic features of
“bright liver pattern” similar to those of hepatic
steatosis [36,37]. Comparing brightness of liver to
brightness of renal cortex (liver–kidney contrast) and
spleen are widely used to exclude the influence of
hepatic fibrosis [38–40]. The subjective assessment
of fatty liver on sonography has substantial observer
variability [41].
Sonographic findings of focal fat deposition or
sparing are not uncommon in fatty liver. Focal fat
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deposition or sparing usually occurs in the porta
hepatis, gallbladder fossa, subcapsular region, and
medial segment adjacent to the falciform ligament
or ligamentum venosum [42,43]. The contour of 
a liver tumor is usually round or oval. In contrast, the
shape of a fatty pseudolesion is often geographic.
Fatty pseudolesions have poorly delineated mar-
gins and do not have mass effects on vessels and
other structures [42,43]. Color Doppler sonography
and contrast agents are useful for the differential
diagnosis of pseudolesions [44,45].
The fatty liver index is calculated by the equa-
tion: 1.03 × AST (IU/L) + 0.152 × triglyceride (mg%)
−49.75 × Doppler perfusion index [46]. The Doppler
perfusion index is the ratio of hepatic arterial to total
liver blood flow [46]. The fatty liver index has been
suggested to be a simple and accurate predictor of
hepatic steatosis [47].
The hepatic artery resistive index is calculated
by the equation: (peak systolic value − end diastolic
value)/peak systolic value [48]. Patients with fatty
liver have a higher hepatic artery resistive index due
to an increased intrahepatic resistance, which can be
reversed by metformin treatment [49,50]. Patients
with fatty liver may also develop abnormal biphasic
or monophasic hepatic vein waveform patterns [51].
Alcoholic hepatitis
Patients with alcoholic hepatitis demonstrate a wide
range of clinical features, from asymptomatic to se-
vere jaundice, ascites, prolonged prothrombin time,
encephalopathy, and hepatorenal failure in full-
blown cases [52–54]. Patients with alcoholic hep-
atitis often have marked hepatomegaly (weight,
> 3,000 g), leukocytosis (rarely > 10,000/mm3) and
a mild degree of fever (usually < 37.5°C). A serum
AST/ALT ratio of > 2.0 is often used in the diagnosis
of alcoholic hepatitis. Alternative diagnoses should
be considered in patients with high serum AST and
ALT levels (> 400 IU/L) [55]. Hepatic systolic bruits
are regarded as a sign of increased hepatic arterial
flow [56]. Patients with alcoholic hepatitis and a
discriminant function of > 32 have a poor progno-
sis [57]. Discriminant function is calculated by the
equation: (4.6 × prothrombin time above control in
seconds) + serum bilirubin. The mortality rate of al-
coholic hepatitis has been considerably improved
by the use of corticosteroids [57], and the compli-
cation of hepatorenal syndrome is reduced by
pentoxyphylline [58].
Alcoholic hepatitis shows marked ballooning
degeneration of hepatocytes and Mallory bodies
with polymorphonuclear leukocyte infiltration main-
ly in the perivenular zone [59–61]. The occurrence of
perivenular and sinusoidal fibrosis is often exten-
sive. The presence of macrovesicular fatty change
and cholestasis are prominent but not essential for
diagnosis.
The clinical features of nonalcoholic steato-
hepatitis are similar to those of alcoholic hepatitis
(Table 1). Patients with alcoholic hepatitis usually
have higher serum bilirubin levels and AST/ALT
ratios of > 2, whereas nonalcoholic steatohepatitis
patients often have ratios of < 2 [62,63]. Alcoholic
hepatitis patients usually have a higher number of
Mallory bodies and a greater degree of perisinu-
soidal fibrosis than patients with nonalcoholic steato-
hepatitis. Polymorphonuclear leukocyte infiltration
in the perivenular zone and portal area is uncom-
mon in nonalcoholic steatohepatitis. Glycogenated
nuclei can be found in patients with nonalcoholic
steatohepatitis [64].
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Table 1. Clinical features of nonalcoholic
steatohepatitis and alcoholic hepatitis
Nonalcoholic Alcoholic 
steatohepatitis hepatitis
Malnutrition + ++ or +++
Hepatomegaly + or ++ ++ or +++
Jaundice + ++ or +++
AST/ALT ratio < 2 > 2
Histology
Mallory bodies + ++ or +++
Sinusoidal fibrosis + ++ or +++
PMN infiltration + ++ or +++
Glycogenated nuclei + −
AST = aspartate aminotransferase; ALT = alanine aminotransferase;
PMN = polymorphonuclear leukocytes.
The clinical features of severe alcoholic hepatitis
presenting with fever, jaundice and abdominal pain
are often confused with those of acute cholecystitis
or biliary infection [65]. The differential diagnosis of
alcoholic hepatitis is clinically important. Acute
cholecystitis patients require surgery, while alcohol-
ic hepatitis patients face a high rate of mortality
following surgery.
Fulminant and subfulminant hepatic failure
caused by viral hepatitis B are not uncommon in
Taiwan [66,67]. A viral hepatitis B infection can be
identified by any positive serum markers including
hepatitis B surface antigen and hepatitis B virus de-
oxyribonucleic acid. Fulminant and subfulminant
hepatic failure are characterized by a shorter clini-
cal course (weeks vs. months), smaller liver size,
AST/ALT ratio of < 1, higher AST and ALT levels of
> 400 initially, less fever and less leukocytosis (in
those without bacterial infection), and predomi-
nant lymphocyte infiltration in comparison to those
with alcoholic hepatitis [68,69] (Table 2). Liver his-
tology offers the most accurate diagnosis. In those
with both viral hepatitis and alcoholism, the histo-
logic findings have shown characteristics of both
viral hepatitis and alcoholic liver disease.
Similar to alcoholic fatty liver, sonographic fea-
tures of alcoholic hepatitis include hepatomegaly
and fatty liver. Sonography can identify complica-
tions such as the presence of ascites, collaterals and
portal hypertension [70–72]. Sonography also helps
rule out cholecystitis and biliary infection.
“Dilated hepatic artery” appears in patients with
acute alcoholic hepatitis [73]. Dilated hepatic artery
is a visible branch of the hepatic artery parallel to
the portal vein branch, and has been diagnosed as
the pseudoparallel channel sign [73].
The mean hepatic artery diameter and peak sys-
tolic velocity are significantly larger in patients with
alcoholic hepatitis than in those with cirrhosis; the
hepatic artery resistive index is lower in patients
with alcoholic hepatitis than in those with cirrhosis
and healthy controls [74,75]. An elevated hepatic
artery diameter or peak systolic velocity measured
by duplex Doppler ultrasound suggests a case of
acute alcoholic hepatitis [76]. The progression of
alcoholic hepatitis to cirrhosis causes an elevation
in hepatic arterial resistive index, indicating that
the impairment of arterial responsiveness is a con-
sequence of fibrosis with vascular distortion [77].
Alcoholic cirrhosis
Similar to alcoholic hepatitis, patients with alcoholic
cirrhosis also present with hepatomegaly. The clin-
ical features of alcoholic cirrhosis range from asymp-
tomatic to decompensated liver function with many
complications [78]. Patients with alcoholic cirrho-
sis often have malnutrition, hypertrophic parotid
glands, vascular spiders, palmar erythema, hepato-
megaly, portal hypertension (collaterals on abdomi-
nal wall, ascites, variceal hemorrhage), feminization
(gynecomastia and hypogonadism), neuropathy
(finger clubbing, Dupuytren’s contractions, and
peripheral neuropathy), and encephalopathy [79].
The presence of a firm liver edge is a useful sign of
alcoholic cirrhosis [80].
Patients with alcoholic cirrhosis have higher
AST and ALT levels, hypoalbuminemia, hyperbiliru-
binemia, anemia, leukocytopenia, thrombocytope-
nia, and prolonged prothrombin time. Reduced
platelet count and function reflect hypersplenism.
Alcoholic Liver Disease
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Liver size Small Huge
Fever + or − +
Leukocytosis + or − < 12,000/mm3
AST:ALT (IU/L) High initially < 300 : < 100
AST/ALT ratio < 1 > 2
Histology




AST = aspartate aminotransferase; ALT = alanine aminotransferase;
PMN = polymorphonuclear leukocytes.
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Alcoholic cirrhosis is characterized by wide-
spread poorly-defined micronodules (≤ 3 mm diam-
eter) and extensive fibrous septa [81,82]. In patients
who have stopped drinking, the nodules become
well demarcated and enlarged (macronodular
> 3 mm) with thin septa. Active alcoholics may have
a variable degree of Mallory bodies, perivenular
fibrosis and fatty liver [83]. Cholestasis presents in
the advanced stage of alcoholic cirrhosis. Hepato-
cellular carcinoma may be present in patients with
advanced cirrhosis, usually in those who have
stopped drinking.
Different from patients with alcoholic hepatitis
(Table 3), patients with alcoholic cirrhosis may have
abused alcohol for months or years. Fever and leu-
kocytosis are not features of alcoholic cirrhosis. The
occurrence of leukocytosis may indicate a bacterial
infection. The AST/ALT ratio is often > 2 in both al-
coholic cirrhosis and alcoholic hepatitis patients. The
hepatic arterial flow is higher in patients with alco-
holic hepatitis and audible arterial bruits but lower
in alcoholic cirrhosis patients.
In contrast to postnecrotic cirrhosis (Table 4),
the liver size in an alcoholic liver cirrhosis patient is
significantly enlarged with a mildly uneven liver sur-
face. The liver size in a viral hepatitis patient is post-
necrotic with shrinkage of the right liver. The liver
surface of a patient with advanced postnecrotic cir-
rhosis is often macronodular. Splenomegaly is com-
mon in postnecrotic cirrhosis but not in alcoholic
cirrhosis. The degree of portal hypertension, col-
laterals, malnutrition and neuropathy in alcoholic
cirrhosis patients is usually much more prominent
than that in postnecrotic cirrhosis; alcoholic cirrhosis
patients have delayed nerve conduction and evoked
potentials [84–86]. Unlike patients with postnecrotic
cirrhosis, patients with alcoholic cirrhosis can have
a variable degree of fatty liver.
Sonographic features of alcoholic cirrhosis in-
clude hepatomegaly, bluntness of liver edge, coarse-
ness of liver parenchymal texture, and fatty liver.
Irregularity of liver surface, hepatomegaly, and at-
tenuation of the ultrasound beam are the most
useful signs for the assessment of cirrhosis [87]. A
scoring system for ultrasound features, including
edge, surface and parenchymal texture of the liver,
has been used for the evaluation of liver fibrosis
stage [88,89]. Cirrhosis can be correctly diagnosed
in 82–88% of patients with chronic liver disease
using a scoring system consisting of 12 clinical and
11 Doppler ultrasonic variables [90].
A decreased portal vein response to respiration
suggests the occurrence of portal hypertension [91].
Platelet count to spleen diameter ratios are sug-
gested to predict the presence of esophageal varices
in compensated cirrhosis [92]. A left portal vein dia-
meter of equal to or greater than the right portal
vein diameter indicates chronic alcoholic liver dis-
ease [93]. Reduced portal flow velocity, portal vein
diameter of > 13 mm, and the lack of mild caliber
variation in the superior mesenteric vein suggest a
diagnosis of portal hypertension [94,95]. Hypos-
plenism is common in alcoholic cirrhosis and less
common in nonalcoholic cirrhosis [96].
Postnecrotic cirrhosis shows an undulating sur-
face and shrinkage of the right liver [97]. Therefore,
the ratio of transverse caudate lobe width to right
lobe width, the ratio of the right lobe to left lobe
longitudinal diameter, and undulating liver surface




Malnutrition + or ++ ++ or +++
Liver size Huge Huge
Hepatic arterial + −
bruit
Fever + + or −
Leukocytes Leukocytosis Leukocytopenia
Platelets − Thrombocytopenia
AST/ALT ratio > 2 > 2
Histology
Mallory bodies ++ or +++ +
Necrosis ++ or +++ +
Bridging fibrosis − +++
AST = aspartate aminotransferase; ALT = alanine aminotransferase.
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are helpful characteristics in assessing postnecrotic
cirrhosis [98,99]. They are, however, not helpful in
the assessment of alcoholic cirrhosis.
Portal hypertension is one of the major compli-
cations of cirrhosis. Noninvasive duplex Doppler
ultrasound has been widely utilized in assessing
the hemodynamics of the portal system [100]. Re-
cent advances in contrast agent technology and
color Doppler sonography in the evaluation of portal
hypertension were recently reviewed [101].
In addition to sonography, various methods
have been used in the assessment of fibrosis, includ-
ing serum transaminases, homeostasis model assess-
ment, AST-to-platelet ratio, FibroTest, European Liver
Fibrosis panel, liver biopsy, computed tomography,
magnetic resonance imaging, transient elastogra-
phy, and genomic and proteomic techniques [102].
Transient elastography has recently been of interest
in the noninvasive assessment of hepatic fibrosis
[103,104]. However, recent publications show that
liver stiffness in viral hepatitis and cirrhosis may be
due to a flare-up of aminotransferases in the absence
of hepatic fibrosis [105,106]. The role of transient
elastography in the noninvasive assessment of
hepatic fibrosis requires further study.
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